Home » Archives
Biotech Firms Target New Treatments for Psoriasis Sufferers
Psoriasis is a chronic, inflammatory skin condition that doesn’t discriminate. Not only can it affect a male or female of any age or nationality, but it can also present itself anywhere on the body... (Continue reading)
Provectus CFO Says “Light of Day” Cancer Cure is Realized in PV-10
Written on 13 Aug, 2009 at 22:22 in Provectus Updates | viewed 1,503 times | 1 Comment
It was almost a decade ago when medical trauma changed the life of Peter Culpepper, CFO at Provectus Pharmaceuticals, and propelled him towards a goal he continues to pursue to this day: Find a cure for cancer.... (Continue reading)
Provectus Pharma Updates Shareholders on 2009 Year-to-date Accomplishments
Written on 11 Aug, 2009 at 16:28 in Provectus Updates | viewed 279 times | 0 Comments
We believe the results show that PV-10 can be a viable treatment for metastatic melanoma, and we are focusing our efforts on completing the 80 patient study, while also making plans for our next steps in development.... (Continue reading)
Cure for Cancer? Provectus PV-10 Story Airs on ABC
Written on 26 Jul, 2009 at 14:15 in Provectus Updates | viewed 482 times | 1 Comment
Does Provectus have a cure for Cancer?... (Continue reading)
New Hope for Cancer Patients
Written on 26 Jun, 2009 at 16:13 in Provectus Updates, Story of the Week | viewed 2,154 times | 7 Comments
Provectus Pharmaceuticals Inc. has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic drug for a broad spectrum of cancers, available for select cancer patients.... (Continue reading)
Provectus Reports Encouraging Clinical Data at ASCO
Dr. Craig Dees, PhD, Chairman and Chief Executive Officer of Provectus said, "The progress we are making in the clinical trials of PV-10 helps pave the way for its possible future as a safe...... (Continue reading)
Provectus PV-10 Makes Waves
Written on 9 Jun, 2009 at 9:58 in Provectus Updates | viewed 1 times | 0 Comments
The American Cancer Society estimates that there are 120,000 patients in the United States with Stage III or Stage IV melanoma, and that 68,000 new cases will be reported in 2009.... (Continue reading)
Hot Topics in Provectus Updates
- New Hope for Cancer Patients viewed 2,154 times
- Provectus CFO Says “Light of Day” Cancer Cure is Realized in PV-10 viewed 1,503 times
- Cure for Cancer? Provectus PV-10 Story Airs on ABC viewed 482 times
- Biotech Firms Target New Treatments for Psoriasis Sufferers viewed 421 times
- Provectus Reports Encouraging Clinical Data at ASCO viewed 290 times
- Provectus Pharma Updates Shareholders on 2009 Year-to-date Accomplishments viewed 279 times
- Provectus PV-10 Makes Waves viewed 165 times
- Provectus PV-10 Makes Waves
(5.00 out of 5) - Cure for Cancer? Provectus PV-10 Story Airs on ABC (5.00 out of 5)
- New Hope for Cancer Patients
(4.86 out of 5) - Provectus Pharma Updates Shareholders on 2009 Year-to-date Accomplishments
(4.00 out of 5) - Biotech Firms Target New Treatments for Psoriasis Sufferers (4.00 out of 5)
- Provectus CFO Says “Light of Day” Cancer Cure is Realized in PV-10 (1.36 out of 5)
- Provectus Reports Encouraging Clinical Data at ASCO (0.00 out of 5)
- Provectus CFO Says “Light of Day” Cancer Cure is Realized in PV-10 - 14 votes
- New Hope for Cancer Patients - 7 votes
- Provectus PV-10 Makes Waves - 1 votes
- Cure for Cancer? Provectus PV-10 Story Airs on ABC - 1 votes
- Provectus Pharma Updates Shareholders on 2009 Year-to-date Accomplishments - 1 votes
- Biotech Firms Target New Treatments for Psoriasis Sufferers - 1 votes
- Provectus Reports Encouraging Clinical Data at ASCO - 0 votes